Zimmer Capital Expenditure vs Cash Beginning of Year Analysis

ZBH Stock

USD 121.52 0.74 0.61%

Trend analysis of Zimmer Biomet Holdings balance sheet accounts such as Common Stock Shares Outstanding of 164.9 M, Total Assets of 13.7 B, Other Current Liabilities of 941.7 M or Total Current Liabilities of 1.5 B provides information on Zimmer Biomet's total assets, liabilities, and equity, which is the actual value of Zimmer Biomet Holdings to its prevalent stockholders. By breaking down trends over time using Zimmer Biomet balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Total Assets Non Current Assets Total

Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zimmer Biomet Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.

About Zimmer Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Zimmer Biomet Holdings at a specified time, usually calculated after every quarter, six months, or one year. Zimmer Biomet Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Zimmer Biomet and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Zimmer currently owns. An asset can also be divided into two categories, current and non-current.

Zimmer Biomet Balance Sheet Chart

Zimmer Biomet Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how Zimmer Biomet Holdings uses and utilizes its capital. It also shows what exactly a company owns and owes.

As of now, Zimmer Biomet's Other Assets are increasing as compared to previous years. The Zimmer Biomet's current Cash is estimated to increase to about 591.2 M, while Common Stock Shares Outstanding is projected to decrease to under 164.9 M.

Common Stock Shares Outstanding Total Assets Other Current Liab Total Current Liabilities

Add Fundamental

Common Stock Shares Outstanding

The total number of shares of a company's common stock that are currently owned by all its shareholders.

Total Assets

Total assets refers to the total amount of Zimmer Biomet assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Zimmer Biomet Holdings books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Zimmer Biomet balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Zimmer Biomet Holdings are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Most indicators from Zimmer Biomet's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Zimmer Biomet Holdings current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zimmer Biomet Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.

As of now, Zimmer Biomet's Tax Provision is increasing as compared to previous years. The Zimmer Biomet's current Enterprise Value Over EBITDA is estimated to increase to 15.42, while Selling General Administrative is projected to decrease to under 2 B.

	2021	2022	2023	2024 (projected)
Gross Profit	4.9B	4.9B	4.7B	3.6B
Total Revenue	6.8B	6.9B	7.4B	5.0B

Gross Profit Total Revenue

Zimmer Biomet fundamental ratios Correlations

	Common Stock Shares Outstanding	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Accounts Payable	Non Current Assets Total	Non Currrent Assets Other	Net Receivables	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Other Liab	Other Assets	Property Plant Equipment	Short Long Term Debt Total	Net Debt	Retained Earnings	Cash	Long Term Debt	Cash And Short Term Investments
Common Stock Shares Outstanding		0.65	0.39	0.75	0.66	0.56	0.74	0.69	0.19	0.55	0.5	0.66	0.18	0.68	0.57	0.23	0.28	0.38	0.04	0.57	0.59	0.64	0.43	-0.5	0.52	-0.7
Total Assets	0.65		0.78	0.86	0.91	0.94	0.92	1.0	0.31	0.95	0.92	0.96	0.67	0.79	0.96	0.32	0.82	0.84	0.27	0.95	0.96	0.95	0.8	0.1	0.93	-0.24
Other Current Liab	0.39	0.78		0.62	0.67	0.79	0.77	0.78	-0.11	0.79	0.75	0.74	0.28	0.47	0.77	-0.05	0.64	0.65	0.01	0.76	0.78	0.76	0.67	0.2	0.77	-0.05
Total Current Liabilities	0.75	0.86	0.62		0.93	0.84	0.91	0.87	0.51	0.81	0.62	0.88	0.5	0.8	0.73	0.48	0.64	0.51	0.4	0.87	0.73	0.76	0.82	-0.24	0.65	-0.47
Total Stockholder Equity	0.66	0.91	0.67	0.93		0.95	0.92	0.89	0.46	0.91	0.67	0.97	0.63	0.77	0.76	0.52	0.81	0.55	0.51	0.96	0.75	0.76	0.93	-0.01	0.69	-0.26
Property Plant And Equipment Net	0.56	0.94	0.79	0.84	0.95		0.91	0.92	0.31	0.98	0.78	0.97	0.65	0.69	0.84	0.4	0.89	0.7	0.42	1.0	0.83	0.82	0.92	0.19	0.8	-0.1
Accounts Payable	0.74	0.92	0.77	0.91	0.92	0.91		0.93	0.19	0.89	0.75	0.94	0.45	0.84	0.82	0.44	0.66	0.63	0.36	0.9	0.83	0.85	0.78	-0.17	0.78	-0.45
Non Current Assets Total	0.69	1.0	0.78	0.87	0.89	0.92	0.93		0.27	0.93	0.92	0.94	0.62	0.82	0.97	0.32	0.76	0.83	0.24	0.93	0.97	0.97	0.76	0.02	0.93	-0.32
Non Currrent Assets Other	0.19	0.31	-0.11	0.51	0.46	0.31	0.19	0.27		0.29	0.1	0.34	0.57	0.19	0.18	0.3	0.47	0.12	0.37	0.38	0.15	0.15	0.51	0.11	0.08	0.07
Net Receivables	0.55	0.95	0.79	0.81	0.91	0.98	0.89	0.93	0.29		0.84	0.94	0.69	0.68	0.88	0.36	0.89	0.77	0.39	0.97	0.86	0.85	0.88	0.2	0.84	-0.09
Non Current Liabilities Total	0.5	0.92	0.75	0.62	0.67	0.78	0.75	0.92	0.1	0.84		0.79	0.61	0.66	0.99	0.09	0.71	0.97	0.01	0.79	0.99	0.97	0.55	0.22	1.0	-0.14
Inventory	0.66	0.96	0.74	0.88	0.97	0.97	0.94	0.94	0.34	0.94	0.79		0.63	0.8	0.85	0.43	0.84	0.69	0.43	0.97	0.85	0.84	0.88	0.08	0.81	-0.23
Other Current Assets	0.18	0.67	0.28	0.5	0.63	0.65	0.45	0.62	0.57	0.69	0.61	0.63		0.39	0.63	0.36	0.82	0.63	0.38	0.68	0.59	0.55	0.67	0.44	0.59	0.22
Other Stockholder Equity	0.68	0.79	0.47	0.8	0.77	0.69	0.84	0.82	0.19	0.68	0.66	0.8	0.39		0.73	0.65	0.43	0.56	0.48	0.71	0.75	0.78	0.52	-0.35	0.7	-0.66
Total Liab	0.57	0.96	0.77	0.73	0.76	0.84	0.82	0.97	0.18	0.88	0.99	0.85	0.63	0.73		0.16	0.74	0.94	0.09	0.85	1.0	0.99	0.64	0.15	0.99	-0.21
Property Plant And Equipment Gross	0.23	0.32	-0.05	0.48	0.52	0.4	0.44	0.32	0.3	0.36	0.09	0.43	0.36	0.65	0.16		0.25	0.05	0.88	0.41	0.16	0.19	0.41	-0.33	0.11	-0.4
Total Current Assets	0.28	0.82	0.64	0.64	0.81	0.89	0.66	0.76	0.47	0.89	0.71	0.84	0.82	0.43	0.74	0.25		0.69	0.39	0.9	0.71	0.66	0.89	0.56	0.71	0.3
Other Liab	0.38	0.84	0.65	0.51	0.55	0.7	0.63	0.83	0.12	0.77	0.97	0.69	0.63	0.56	0.94	0.05	0.69		0.0	0.71	0.93	0.91	0.46	0.32	0.95	-0.03
Other Assets	0.04	0.27	0.01	0.4	0.51	0.42	0.36	0.24	0.37	0.39	0.01	0.43	0.38	0.48	0.09	0.88	0.39	0.0		0.43	0.06	0.07	0.51	-0.02	0.03	-0.08
Property Plant Equipment	0.57	0.95	0.76	0.87	0.96	1.0	0.9	0.93	0.38	0.97	0.79	0.97	0.68	0.71	0.85	0.41	0.9	0.71	0.43		0.84	0.83	0.93	0.18	0.8	-0.11
Short Long Term Debt Total	0.59	0.96	0.78	0.73	0.75	0.83	0.83	0.97	0.15	0.86	0.99	0.85	0.59	0.75	1.0	0.16	0.71	0.93	0.06	0.84		1.0	0.61	0.1	0.99	-0.26
Net Debt	0.64	0.95	0.76	0.76	0.76	0.82	0.85	0.97	0.15	0.85	0.97	0.84	0.55	0.78	0.99	0.19	0.66	0.91	0.07	0.83	1.0		0.59	0.01	0.98	-0.34
Retained Earnings	0.43	0.8	0.67	0.82	0.93	0.92	0.78	0.76	0.51	0.88	0.55	0.88	0.67	0.52	0.64	0.41	0.89	0.46	0.51	0.93	0.61	0.59		0.24	0.57	0.05
Cash	-0.5	0.1	0.2	-0.24	-0.01	0.19	-0.17	0.02	0.11	0.2	0.22	0.08	0.44	-0.35	0.15	-0.33	0.56	0.32	-0.02	0.18	0.1	0.01	0.24		0.18	0.92
Long Term Debt	0.52	0.93	0.77	0.65	0.69	0.8	0.78	0.93	0.08	0.84	1.0	0.81	0.59	0.7	0.99	0.11	0.71	0.95	0.03	0.8	0.99	0.98	0.57	0.18		-0.18
Cash And Short Term Investments	-0.7	-0.24	-0.05	-0.47	-0.26	-0.1	-0.45	-0.32	0.07	-0.09	-0.14	-0.23	0.22	-0.66	-0.21	-0.4	0.3	-0.03	-0.08	-0.11	-0.26	-0.34	0.05	0.92	-0.18

Click cells to compare fundamentals

Zimmer Biomet Account Relationship Matchups

Zimmer Biomet fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Common Stock Shares Outstanding	206.7M	207M	210.4M	210.3M	209.7M	164.9M
Total Assets	24.6B	24.4B	23.5B	21.1B	21.5B	13.7B
Other Current Liab	1.9B	1.6B	511M	985M	1.3B	941.7M
Total Current Liabilities	3.4B	2.6B	3.5B	2.4B	2.9B	1.5B
Total Stockholder Equity	12.4B	12.2B	12.7B	12.0B	12.5B	7.4B
Property Plant And Equipment Net	2.1B	2.0B	1.8B	1.9B	2.3B	1.4B
Accounts Payable	400.9M	330M	306.5M	354.1M	379.8M	228.6M
Non Current Assets Total	19.9B	19.3B	18.6B	16.6B	16.9B	10.3B
Non Currrent Assets Other	980.1M	969.4M	2.3B	630.8M	559.1M	561.5M
Net Receivables	1.4B	1.5B	1.3B	1.4B	1.4B	975.8M
Liabilities And Stockholders Equity	24.6B	24.4B	23.5B	21.1B	21.5B	13.7B
Non Current Liabilities Total	8.8B	9.7B	7.3B	6.7B	6.2B	4.8B
Inventory	2.4B	2.5B	2.1B	2.1B	2.4B	1.4B
Other Current Assets	357.1M	377.8M	607.1M	522.9M	366.1M	363.9M
Other Stockholder Equity	2.2B	2.4B	2.6B	2.6B	2.3B	2.4B
Total Liab	12.2B	12.2B	10.8B	9.0B	9.0B	6.3B
Property Plant And Equipment Gross	2.1B	2.0B	6.1B	6.5B	6.8B	7.1B
Total Current Assets	4.7B	5.1B	4.9B	4.4B	4.6B	3.4B
Accumulated Other Comprehensive Income	(241.9M)	(297.8M)	(231.6M)	(179.3M)	(191M)	(181.5M)
Other Liab	1.9B	2.0B	1.9B	1.1B	1.3B	1.2B
Other Assets	652.9M	969.4M	1.1B	1.1B	1.3B	1.4B
Property Plant Equipment	2.1B	2.0B	2.0B	1.9B	2.2B	1.4B
Short Long Term Debt Total	8.2B	8.1B	7.1B	5.7B	6.0B	4.3B
Net Debt	7.6B	7.3B	6.7B	5.3B	5.6B	3.7B
Retained Earnings	10.4B	10.1B	10.3B	9.6B	10.4B	6.8B
Cash	617.9M	802.1M	378.1M	375.7M	415.8M	591.2M
Long Term Debt	6.7B	7.6B	5.5B	5.2B	5.0B	4.0B
Cash And Short Term Investments	617.9M	802.1M	378.1M	375.7M	415.8M	732.9M
Good Will	9.6B	9.3B	8.9B	8.6B	8.8B	6.0B
Intangible Assets	7.3B	7.1B	5.5B	5.1B	4.9B	4.2B
Treasury Stock	(6.7B)	(6.7B)	(6.7B)	(6.9B)	(6.2B)	(6.5B)
Net Tangible Assets	(4.5B)	(4.1B)	(2.8B)	(1.6B)	(1.5B)	(1.5B)
Noncontrolling Interest In Consolidated Entity	4.7M	5.2M	5.7M	6.7M	6.0M	5.7M
Retained Earnings Total Equity	10.4B	10.1B	10.3B	9.6B	11.0B	9.1B
Capital Surpluse	8.9B	9.1B	9.3B	9.5B	10.9B	7.5B

Zimmer Biomet Investors Sentiment

The influence of Zimmer Biomet's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Zimmer. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.

Investor biases related to Zimmer Biomet's public news can be used to forecast risks associated with an investment in Zimmer. The trend in average sentiment can be used to explain how an investor holding Zimmer can time the market purely based on public headlines and social activities around Zimmer Biomet Holdings. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.

Zimmer Biomet's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Zimmer Biomet's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Zimmer Biomet's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Zimmer Biomet.

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Zimmer Biomet in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Zimmer Biomet's short interest history, or implied volatility extrapolated from Zimmer Biomet options trading.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

GOOG	Alphabet Inc Class C
DD	Dupont De Nemours
C	Citigroup

When determining whether Zimmer Biomet Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Zimmer Biomet's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Zimmer Biomet Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Zimmer Biomet Holdings Stock:

How To Invest In Zimmer

Details

Is Zimmer Stock a good investment?

Details

What is Zimmer Biomet's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Note that the Zimmer Biomet Holdings information on this page should be used as a complementary analysis to other Zimmer Biomet's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Complementary Tools for Zimmer Stock analysis

When running Zimmer Biomet's price analysis, check to measure Zimmer Biomet's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zimmer Biomet is operating at the current time. Most of Zimmer Biomet's value examination focuses on studying past and present price action to predict the probability of Zimmer Biomet's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zimmer Biomet's price. Additionally, you may evaluate how the addition of Zimmer Biomet to your portfolios can decrease your overall portfolio volatility.

	Performance Analysis Check effects of mean-variance optimization against your current asset allocation
	Equity Valuation Check real value of public entities based on technical and fundamental data
	Technical Analysis Check basic technical indicators and analysis based on most latest market data
	Content Syndication Quickly integrate customizable finance content to your own investment portal
	Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios
	Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios
	Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum
	Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
	Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios
	Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments
	Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios.

Is Zimmer Biomet's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zimmer Biomet. If investors know Zimmer will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zimmer Biomet listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.16)

Dividend Share

0.96

Earnings Share

4.88

Revenue Per Share

35.43

Quarterly Revenue Growth

0.063

The market value of Zimmer Biomet Holdings is measured differently than its book value, which is the value of Zimmer that is recorded on the company's balance sheet. Investors also form their own opinion of Zimmer Biomet's value that differs from its market value or its book value, called intrinsic value, which is Zimmer Biomet's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zimmer Biomet's market value can be influenced by many factors that don't directly affect Zimmer Biomet's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Zimmer Biomet's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zimmer Biomet is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zimmer Biomet's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Zimmer Capital Expenditure vs Cash Beginning of Year Analysis

About Zimmer Balance Sheet Analysis

Zimmer Biomet Balance Sheet Chart

Common Stock Shares Outstanding

Total Assets

Total Current Liabilities

Zimmer Biomet fundamental ratios Correlations

Zimmer Biomet Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Zimmer Biomet fundamental ratios Accounts

Zimmer Biomet Investors Sentiment

Also Currently Popular

Complementary Tools for Zimmer Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Non Current Assets Total	+ 1.0	Total Assets
Property Plant Equipment	+ 1.0	Property Plant And Equipment Net
Long Term Debt	+ 1.0	Non Current Liabilities Total
Short Long Term Debt Total	+ 1.0	Total Liab
Net Debt	+ 1.0	Short Long Term Debt Total
Total Liab	+ 0.99	Non Current Liabilities Total

Cash And Short Term Investments	- 0.7	Common Stock Shares Outstanding
Cash And Short Term Investments	- 0.66	Other Stockholder Equity
Cash	- 0.5	Common Stock Shares Outstanding
Cash And Short Term Investments	- 0.47	Total Current Liabilities
Cash And Short Term Investments	- 0.45	Accounts Payable
Cash And Short Term Investments	- 0.4	Property Plant And Equipment Gross